Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs

Nucera, E., Basta, F., Buonomo, A., Mezzacappa, S., Margiotta, D., Antonelli Incalzi, R., Schiavino, D., A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab, <<JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY>>, 2017; (27): 382-384 [http://hdl.handle.net/10807/120188]

A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab

Nucera
Primo
;
F; Buonomo;A; Mezzacappa;Dp; Antonelli Incalzi;R; Schiavino
Ultimo
2017

Abstract

Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs
Inglese
Nucera, E., Basta, F., Buonomo, A., Mezzacappa, S., Margiotta, D., Antonelli Incalzi, R., Schiavino, D., A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab, <<JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY>>, 2017; (27): 382-384 [http://hdl.handle.net/10807/120188]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/120188
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 12
social impact